Qube Research & Technologies Ltd
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in INDV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,086,984
New position
Shares Held
429,363
first reported quarter
Ownership
0.352%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $391,792,991 across 21 Drug Manufacturers - Specialty & Generic names. INDV ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,666,750 | $130,597,792 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,441 | $73,198,044 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
686,853 | $33,071,971 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
498,198 | $25,751,854 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
4,114,425 | $23,863,665 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
621,935 | $20,567,390 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
210,130 | $16,158,997 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
429,363 | $13,086,984 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,086,984 | 429,363 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||